Clinical Trials Directory

Trials / Completed

CompletedNCT01999881

Impacts of Exercise on Prognostic Biomarkers in Lung Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This randomized pilot clinical trial studies exercise intervention in improving quality of life and exercise capacity and reducing inflammation and oxidative stress in patients with lung cancer and their support persons. Exercise therapy may help improve quality of life, may increase exercise capacity, and may reduce inflammation and oxidative stress in patients with lung cancer and their supporters.

Detailed description

PRIMARY OBJECTIVES: I. Determine the effect of an eight-week exercise intervention on biomarkers of inflammation, oxidative stress, exercise capacity, and quality of life in lung cancer patients. SECONDARY OBJECTIVES: I. Determine the effect of an eight-week exercise intervention on markers of stress and quality of life in the support person of lung cancer patients. OUTLINE: Participants are randomized to 1 of 2 arms. ARM A: Patients and their support persons undergo a supervised combined aerobic exercise comprising walking, cycling, or video-based aerobics and strength training using resistance bands for 40 minutes 2 days a week at the University of Wisconsin Hospital and Clinic (UWHC) and 3 days a week at home over 8 weeks. ARM B: Patients and their support persons undergo the usual care over 8 weeks.

Conditions

Interventions

TypeNameDescription
BEHAVIORALexercise interventionReceive aerobic and exercise intervention
PROCEDUREstandard follow-up careReceive usual care
PROCEDUREquality-of-life assessmentAncillary studies
OTHERlaboratory biomarker analysisCorrelative studies

Timeline

Start date
2013-12-01
Primary completion
2015-07-01
Completion
2016-02-01
First posted
2013-12-03
Last updated
2019-11-18

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01999881. Inclusion in this directory is not an endorsement.